SuperworthPyxis Oncology shares outstanding PYXS
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 64M
- On a year earlier
- +3.3%
- more shares
Pyxis Oncology had 64M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 63M | +3% |
| FY2024 | 61.2M | +38% |
| FY2023 | 44.4M | +28% |
| FY2022 | 34.8M | +2838% |
| FY2020 | 1.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 64M | +3% | |
| Q1 FY26 | 63.5M | +4% | |
| Q4 FY25 | 63M | +3% | |
| Q3 FY25 | 62.6M | +3% | |
| Q2 FY25 | 61.9M | +2% | |
| Q1 FY25 | 61M | +19% | |
| Q4 FY24 | 61.2M | +38% | |
| Q3 FY24 | 60.7M | +47% | |
| Q2 FY24 | 60.5M | +58% | |
| Q1 FY24 | 51.3M | +45% | |
| Q4 FY23 | 44.4M | +28% | |
| Q3 FY23 | 41.3M | +27% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Pyxis Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.